Potent, selective and competitive protein kinase C (PKC) inhibitor. Selective for PKCβI and PKCβII (IC50 values are 4.7 and 5.9 nM respectively) over PKCα by 76- and 61- fold respectively. Shows antinociceptive actions against and improves vascular function in diabetes.
Solubility & Handling
Storage instructions
-20°C
Solubility overview
Soluble in DMSO (20mM)
Important
This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use.
(S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta.
Jirousek MR et al (1996) J Med Chem 39(14) : 2664-71.